The enteric nervous system (ENS) is the largest branch of the peripheral nervous system, comprising complex networks of neurons and glia, which are present throughout the gastrointestinal tract. Although development of a fully functional ENS is required for gastrointestinal motility, little is known about the ontogeny of ENS function in humans. We studied the development of neuronal subtypes and the emergence of evoked electrical activity in the developing human ENS. METHODS: Human fetal gut samples (obtained via the MRC-Wellcome Trust Human Developmental Biology Resource-UK) were characterized by immunohistochemistry, calcium imaging, RNA sequencing, and quantitative real-time polymerase chain reaction analyses. RESULTS: Human fetal colon samples have dense neuronal networks at the level of the myenteric plexus by embryonic week (EW) 12, with expression of excitatory neurotransmitter and synaptic markers. By contrast, markers of inhibitory neurotransmitters were not observed until EW14. Electrical train stimulation of internodal strands did not evoke activity in the ENS of EW12 or EW14 tissues. However, compound calcium activation was observed at EW16, which was blocked by the addition of 1 mmol/L tetrodotoxin. Expression analyses showed that this activity was coincident with increases in expression of genes encoding proteins involved in neurotransmission and action potential generation. CONCLUSIONS: In analyses of human fetal intestinal samples, we followed development of neuronal diversity, electrical excitability, and network formation in the ENS. These processes are required to establish the functional enteric circuitry. Further studies could increase our understanding of the pathogenesis of a range of congenital enteric neuropathies.
T he enteric nervous system (ENS), the largest branch of the peripheral nervous system, is composed of complex networks of neurons and glia, which are present throughout the gastrointestinal tract. 1 The ENS is derived primarily from vagal neural crest cells, 2 which enter the foregut at embryonic day (E) 9 in mice and migrate in a rostrocaudal fashion to colonize the entirety of the developing gut by E14. 3, 4 In avian and mouse models, a smaller population of sacral neural crest-derived cells has also been shown to contribute to the developing ENS in the terminal hindgut. 2, 5 During ENS development, enteric neural crest cells (ENCCs) proliferate and migrate extensively in a highly complex manner, with elongation of migratory chains of ENCCs throughout the gut, including transmesenteric migration pathways that have been shown in the mouse. 6 Recent murine work has proposed that topographically, the ENS is built from parallel, overlapping columns of clonally derived ENCCs. Such topographic organization relies on residual founder ENCCs at the level of the myenteric plexus, which give rise to progeny that extend through the width of the gut wall and are arranged along the serosamucosa axis. 7 Previous work has shown the spatiotemporal development of neuronal subtypes in the mouse gut, with the appearance of nitrergic neuronal nitric oxide synthaseexpressing neurons at approximately E12.5 8 and subsequent development of cholinergic neurons expressing choline acetyltransferase (ChAT) at E14.5. 9 Furthermore, physiological studies in the murine colon have shown the emergence of spontaneous calcium transients in ENCCs at the migratory wavefront at E12.5 10 and the emergence of induced electrical activity in colonic networks at approximately E15.5.
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Despite these significant advances in our knowledge regarding the development of the ENS in animal models, insight to many of these developmental milestones in the human ENS is lacking. Previous work has provided evidence of similar rostrocaudal colonization in the human gut, whereby ENCCs enter the foregut at embryonic week (EW) 4 and migrate in an oro-anal fashion to fully colonize the length of the gut by EW7. 12, 13 After ENCC colonization, development and maturation of the tunica muscularis occurs, with rostrocaudal differentiation of the smooth muscle layers and development of interstitial cell of Cajal networks. 13 Hence, at approximately EW11, the human colon has adopted an anatomically mature phenotype. These studies established the critical time frame for colonization and development of the ENS in human fetal gut tissues. However, there is a paucity of evidence regarding the development of neuronal subtypes or of coordinated electrical activity in the human ENS, which are vital processes for the establishment of the normal functional circuitry that underpins neuromuscular function of the gastrointestinal tract.
Here, we show that the spatiotemporal development of multiple enteric neuronal subtypes in the human fetal colon occurs in the early second trimester. We further show the onset of coordinated neural activity in the human enteric neural network and show that this activity is coincident with increases in expression of various genes involved in neurotransmission and action potential generation. Thus, we propose that the period from the late first trimester to the early second trimester is crucial for the development of a repertoire of enteric neural subtypes and to the establishment of a functional ENS.
Methods

Human Samples
Human fetal colonic samples were obtained via the Joint MRC/Wellcome Trust Human Developmental Biology Resource under informed ethical consent with Research Tissue Bank ethical approval (08/H0712/34þ5 and 08/H0906/ 21þ5).
Immunohistochemistry
Immunohistochemistry was performed on fetal wholemount colonic segments and cryostat sections, as previously described 14 (see Supplementary Materials and Methods) by using the primary and secondary antibodies listed in Supplementary Tables 1 and 2 , respectively.
Calcium Imaging
Fetal intestinal samples were obtained as previously described, and calcium imaging was performed as previously reported. 15 After tissue excision and preparation (see Supplementary Materials and Methods), electrical train stimulation (2 s, 20 Hz of 300-ms electrical pulses) (Electronic Stimulator 1001; ADInstruments, Oxford, UK) was applied via a platinum/iridium electrode, and images were collected with OptoFluor software (Cairn Research Limited, Faversham, UK).
RNA Extraction and Sequencing
Total RNA from the hindgut of 1 individual embryo from each time point (EW12, EW14, and EW16) was extracted with the RNeasy kit and protocol (Qiagen, Venlo, The Netherlands). RNA quantity and quality were determined using the Lab-onChip RNA 6000 Nano (Agilent Technologies, Santa Clara, CA) on the Agilent 2100 Bioanalyzer. 
Quantitative Real-Time Polymerase Chain Reaction
Complementary DNA was prepared from hindgut samples of 3 embryos from each time point (EW12, EW14, and EW16), and quantitative real-time polymerase chain reaction (qRT-PCR) was performed on each sample with technical triplicates, as described before. 16 Expression levels were normalized with 2 housekeeping genes (ACTB and GAPDH) and averaged. The primers used are described in Supplementary Table 3 .
Statistical Analysis
Data are expressed as mean ± standard error of the mean. Differences in the data were evaluated between groups using 1-way analysis of variance (ANOVA), and intergroup differences were determined by Tukey test or unpaired Student t test. P values < .05 were taken as statistically significant. The n values reported refer to the number of individual fetal colonic segments used for each protocol.
Results
Development and Maturation of Key ENS Cell Types
To assess the development and maturation of the human fetal ENS, immunohistochemistry was performed on proximal colonic cryosections at EW12-16. This approach and time frame allowed for fate mapping of typical ENS cell types, including enteric neurons and glia, in the second trimester. Human fetal colonic samples at EW12 displayed robust neuron-specific TuJ1 expression, highlighting the presence of enteric neurons. The TuJ1 þ cells, termed neurons from here on, were located in multiple discrete ganglia-like structures at the level of the myenteric plexus WHAT YOU NEED TO KNOW
BACKGROUND AND CONTEXT
Despite advances in our knowledge regarding the functional development of the gut nervous system in animal models, much of the knowledge regarding this process in humans is still lacking.
NEW FINDINGS
The researchers defined the development of a number of nerve cells and the onset of electrical activity within the developing human gut nervous system.
LIMITATIONS
This study relied on small sample sizes for each timepoint examined, due to the scarcity of human fetal gut material.
IMPACT
These findings provide a timeframe for the development of a functional gut nervous system, within human gestation, which was previously unknown.
( Figure 1A and D, arrows). Few TuJ1 þ neurons were identified in the submucosal layer at EW12 ( Figure 1A and D, arrowheads). At this stage, SM22 staining, a marker of mature smooth muscle, showed 2 distinct muscle layers ( Figure 1A and D) , the inner circular layer ( Figure 1D , asterisk) and outer longitudinal layer ( Figure 1D, hash) , reflective of the morphology of the mature human enteric neuromusculature. Further maturation of the tunica muscularis was observed with thickening of muscle layers at EW14 ( Figure 1B and E) and EW16 ( Figure 1C and F) . Maturation and thickening of the circular muscle was more apparent across this time frame, with SM22 þ smooth muscle cells adopting a more uniform phenotype, with elongated nuclei in the circumferential orientation ( Figure 1E and F, asterisk). Maturation of the ENS was also observed by EW14, as TuJ1 þ ganglia in the myenteric plexus gradually coalesce and increase in size by EW14 ( Figure 1B and E, arrows). At this stage, more robust TuJ1 þ expression was identified in the submucosal layer, forming a rudimentary and interrupted submuscosal plexus ( Figure 1B and E, arrowheads), with neuronal projections extending into mucosal villi. At EW16, TuJ1 þ expression and localization were still observed in the myenteric plexus, with further restriction of ganglia-like structures ( Figure 1C and F, arrows). Further development of TuJ1 þ neurons in the submucosal regions showed a more continuous submucosal plexus ( Figure 1C and F, arrowheads), and TuJ1 þ neuronal projections were also observed extending into mucosal villi.
To assess the development of enteric glial cells, expression of S100 was examined with immunohistochemistry over a similar time frame. At EW12, S100 expression was observed in the myenteric plexus alongside robust TuJ1 expression (Figure 2A , D, and G, arrows). Such S100 expression appeared in isolation at this stage, with little coexpression of TuJ1 in either the myenteric plexus or submucosal layer (Figure 2A, D, G, arrows) . At EW14, occasional and weak coexpression of S100 and TuJ1 was observed in some cells, both in the myenteric ganglia ( Figure 2B , E, and H, arrows) and in the submucosal layer ( Figure 2B , E, and H, arrowheads). Weak S100 expression was additionally observed as a diffuse single cell layer on the serosal surface of EW14 tissue ( Figure 2B , E, and H, hash). However, by EW16, this diffuse serosal S100 expression was no longer evident, and both S100 þ glia ( Figure 2C , F, and I, arrowheads) and TuJ1 þ neurons ( Figure 2C , F, and I, arrows) were observed discretely in close apposition in myenteric ganglia and in the submucosal plexus with little coexpression.
Neuronal Subtype Development in the Human ENS
Having shown the development of enteric neurons and glia, as well as the maturation of ganglia from EW12 to EW16, we further assessed the development of specific neuronal subtypes in the human fetal colon. Immunohistochemistry of proximal colonic sections at EW12 showed coexpression of TuJ1 and vesicular acetylcholine transporter (VAChT) ( Figure 3A and Supplementary Figure 1A , arrows) and substance P (Sub P) in ganglia-like structures in the myenteric plexus ( Figure 3D and Supplementary  Figure 2A , arrows). Robust VAChT þ expression was observed in myenteric ganglia ( Figure 3B and C and Supplementary Figure 1B and C, arrows) and in the submuscosal region ( Figure 3B and C, arrowheads) at both EW14 and EW16, respectively. Sub P was also observed to be more robustly expressed in myenteric ganglia ( Figure 3E and F and Supplementary Figure 2B and C, arrows) and in the submuscosal region at EW14 and EW16 ( Figure 3E and F, arrowheads). Examination of inhibitory neuronal subtypes showed no neuronal nitric oxide (nNOS) ( Figure 3G and Supplementary Figure 3A Figure 4C , arrows) expression was observed at the level of the myenteric plexus. nNOS þ neurons at EW16 appeared to remain restricted to the myenteric region, with little coexpression in TuJ1 þ neurons throughout the remaining gut wall ( Figure 3I , arrowheads). By contrast, strong VIP þ expression was observed in the submucosal region and in villus structures at EW16 ( Figure 3L , arrowheads). Taken together, these data suggest that the initial development of excitatory neurons (VAChT and weak coexpression of S100 and TuJ1 was observed in myenteric ganglia (arrows) and in the submucosal layer (arrowheads). Weak S100 expression was also observed as a diffuse layer on the serosal surface (#). (C, F, I) At EW16, discrete S100 þ glia (arrowheads) and TuJ1 þ neurons (arrows) were observed in myenteric ganglia and in the submucosal plexus. Scale bars, 50 mm (A-F), 25 mm (G-I). DAPI, 4 0 ,6-diamidino-2-phenylindole. , coexpression of TuJ1 and Sub P was observed in the myenteric plexus (arrows) alone. However, robust coexpression was observed in the myenteric plexus (arrows) and in the submucosal region (arrowheads) at (E) EW14 and (F) EW16. (G-I) At (G) EW12, expression of nNOS was not observed alongside TuJ1 in any region across the gut wall. At (H) EW14, coexpression of nNOS and TuJ1 was restricted to the myenteric plexus (arrows). TuJ1 þ neurons were observed in the submuscosal region extending into the villus crypts. These TuJ1 þ neurons did not express nNOS. At (I) EW16, nNOS and TuJ1 coexpression was restricted in the myenteric plexus (arrows), with little nNOS coexpression in TuJ1 þ neurons throughout the remaining gut wall (arrowheads). (J-L) TuJ1 expression was found in the myenteric plexus and sparsely in the submucosal region at (J) EW12 in the absence of VIP staining. At (K) EW14, coexpression of nNOS and TuJ1 was observed in the myenteric plexus (arrows) and the submuscosal region and extending into the villus crypts (arrowheads). At (L) EW16, robust nNOS and TuJ1 coexpression was present in the myenteric plexus (arrows), the submuscosal region, and extending into the villus crypts (arrowheads). Scale bars, 50 mm. DAPI, 4 0 ,6-diamidino-2-phenylindole.
and Sub P) in the human fetal colon occurs before EW12, whereas the development of inhibitory neurons (nNOS and VIP) occurs later, between EW12 and EW14.
Having shown the maturation of the fetal ENS using cryosections, including the birth-dating of neuronal subtypes, we further assessed neural development in wholemount colonic preparations. Similar to cryosections, immunohistochemistry of EW12 whole-mount colonic preparations showed robust TuJ1 þ neural networks at the level of the myenteric plexus. Here, TuJ1 þ neurons were observed in complex anastomosing networks with ganglialike structures ( Figure 4A , arrows) and interganglionic neuronal connections ( Figure 4B, arrowheads) . At EW14 ( Figure 4B ) and EW16 ( Figure 4C ), TuJ1 þ immunohistochemistry showed further network maturation, including the development of dense neural connections ( Figure 4B and C, arrows) and the formation of discrete ganglion structures ( Figure 4B and C, arrowheads).
Development of Coordinated Electrical Activity in the Human ENS
To assess the development of coordinated electrical activity in fetal tissues, calcium imaging of whole-mount colonic preparations was performed from EW12 to EW16. Little basal activity was observed in the presumptive ENS of EW12, EW14, or EW16 colonic preparations. However, occasional calcium transients in underlying smooth muscle cells were observed in basal conditions (Supplementary Movies 1-3). Upon electrical point stimulation, no stimulation-induced calcium transients were observed in 3 of 3 EW12 colonic samples (DF/F 0 ¼ 1.033 ± 0.002, n ¼ 3) ( Figure 4D , G, J, M, and N and Supplementary Movie 1). Similarly, electrical stimulation did not elicit calcium transients in fetal tissues in most (4/5) EW14 preparations (DF/ F 0 ¼ 1.055 ± 0.029, n ¼ 5, P ¼ .813 by Tukey test) ( Figure 4E , H, K, M, and N and Supplementary Movie 2). By EW16, there were statistically significant differences in mean values of stimulation-induced calcium transients between control EW12, EW14, and EW16 groups, as determined by 1-way analysis of variance (ANOVA) (F 2,8 ¼ 11.36, P ¼ .0046), with 3 of 3 EW16 colonic preparations displaying compound activation of the ENS (1.211 ± 0.026, n ¼ 3) ( Figure 4F , I, L, M, and N and Supplementary Movie 3) compared with either EW12 (P ¼ .007, Tukey test) or EW14 (P ¼ .008, Tukey test). Additionally, this stimulationinduced activation of enteric neuronal networks at EW16 was found to be blocked (3/3) in the presence of 1 mmol/L tetrodotoxin (1.029 ± 0.012, n ¼ 3), compared with stimulation in control conditions (1.211 ± 0.026; n ¼ 3; P ¼ .0028, Student t test) ( Figure 4O and Supplementary Movie 4). This result suggests the presence of voltagedependent sodium channels in the ENS at EW16 of human development.
To determine if the stimulation-induced compound activation observed at this stage could be due to the development of synaptic connectivity, we performed immunohistochemistry for synaptophysin across each of the time points examined. At EW12, coexpression of TuJ1 and synaptophysin was observed ( Figure 5A , arrows) in ganglialike structures of the myenteric plexus. This coexpression was maintained at both EW14 and EW16 ( Figure 5B and C, arrows), with additional coexpression visualized in the submuscosal region ( Figure 5B and C, arrowheads) . These results suggest that although synaptic protein expression is in place by EW12, the development of simulation-induced coordinated electrical activity is not established until later in development, between EW14 and EW16. To investigate whether postsynaptic specialization is a limiting factor in the development of compound activation in the developing ENS, pharmacologic activation and blockade of nicotinic neurotransmission were performed at EW14 and EW16, respectively. At EW14, application of 1 mmol/L acetylcholine led to significant contraction of fetal colonic tissue. This application did not result in compound activation of the presumptive ENS ( Figure 5D 
Transcriptional Changes in the Human Fetal Gut
To determine whether transcriptional changes might account for the apparent onset of electrical activity between EW14 and EW16, RNA sequencing analysis was performed across all developmental stages (EW12, EW14, and EW16) with stringent and more lenient read alignment procedures. Only minor differences between these procedures were observed (see Supplementary Materials sections "Lenient Alignment" and "Stringent Alignment"), allowing us to discriminate the expressions of different candidate gene homologues. With either one of these alignments, 13,828 genes were found to be expressed during EW12-EW16. Very low transcript levels were detected for 8,612 genes, making interpretation difficult, because such low levels may represent noise. For 30,828 genes, we were unable to detect any transcripts. With stage-specific analysis parameters (counts-per-million > 2 in specific embryonic week and <1 in the remaining 2), few of the detected genes were found to be specific for each of the time points included in this study (43 in EW12, 70 in EW14, and 80 in EW16). Many genes were also found to have different expression levels between EW12 and EW14 (n ¼ 2265), between EW14 and EW16 (n ¼ 3610), and between EW12 and EW16 (n ¼ 3792). Most of these genes are known to affect many canonical pathways and biological functions, more than expected by chance alone. Comparing EW12 to EW14 and EW16, we could see that, from a neuronal perspective, interesting characteristics and biological functions such as axogenesis, neuronal and synaptic development, quantity of neurons and neuronal tissue, sprouting, and ion transport were significantly enriched (negative Z-score). Moreover, we observed that expression of messenger RNA encoding proteins that may contribute to functions such as Ca 2þ flux and cation, divalent cation, ionic, and Ca 2þ mobilization, were significantly up-regulated (negative Z-score) compared with earlier time points (EW12-EW14) but were down-regulated (positive Z-score) at later stages (EW14-EW16) (see Supplementary Materials section "Pathway Enrichment"). To validate these results, we specifically looked at the expression levels of 36 genes known to encode ion channels, neuronal subtypes, glial cells, synapsins, and semaphorins. We initially analyzed expression levels by plotting their counts-per-million values in a heatplot ( Figure 6 and Supplementary Figure 5) . This approach showed up-regulation of almost all of these genes in EW14 and EW16 colonic tissue compared with EW12. We also performed qRT-PCR analysis on 3 independent colonic samples from each developmental stage (EW12-EW16). The results obtained showed an up-regulation of the expression levels of candidate Na þ (SCN) and K þ (KNCQ) channelexpressing genes known to be involved in the generation and modulation of ENS action potentials. Each candidate ion channel examined (SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, KCNQ2, and KCNQ3) displayed a trend toward increased expression between EW12 and EW16 ( Figure 7A and Supplementary Table 4 ). SCN3A, which encodes a TTXsensitive, fast-inactivating, voltage-gated Na þ channel and plays a major role in neuronal action potentials, displayed a linear increasing trend in expression, with a 1.10-fold increase at EW14 and a 1.44-fold increase at EW16, compared with EW12 colonic tissue. Similarly, SCN9A, which has been shown to modify neuron excitability during the relative refractory period, displayed a linear increasing trend in expression, with a 1.51-fold increase at EW14 and a 2.13-fold increase at EW16, compared with EW12 colonic tissue. In contrast, other candidate genes, KCNQ2 and KCNQ3, which encode delayed rectifier K þ channels and act to regulate membrane excitability and the threshold for action potential generation, displayed increases in expression between EW12 and EW14, with subsequent reduction in expression at EW16. Up-regulation of these ion channels might account for evoked activity at EW16. Concerning the expression levels of several ENS candidate genes, the expression patterns observed in terms of neuronal subtypes corresponded to the temporal development pattern observed in immunohistochemical analysis. VAChT expression was maintained at a relatively constant level across the 3 developmental time points ( Figure 7B and Supplementary Table 4), whereas nNOS expression displayed an increase at EW14, which corresponds to the birthdating of this neuronal subtype. Expression of both TAC-1, a precursor of Sub P, and VIP also mimicked immunohistochemical observations, with increasing expression up to EW16. S100 expression increased at EW14, which appears to match a possible transitional and transient period of S100 þ glial cell development, as visualized by immunofluorescence. SYN1 expression remained relatively constant across each time point, supporting our earlier findings that synaptic proteins are already expressed by EW12. Finally, SEMA3A, a gut morphogen previously found to affect ENS development, showed a modest increase in expression between EW12 and EW14, which appeared to plateau at EW16. Taken together, these data suggest that rather than a significant shift in expression of a single ion channel or ion channel family, a trend in increasing expression of a range of critical ion channels appears to account for the changes in ENS neurotransmission across this 4-week period. These data also confirm our immunohistochemical findings, further supporting the idea that the developmental time window between EW12 and EW16 is critical for the establishment of a repertoire of neuronal subtypes and enteric glia.
Discussion
Extensive murine studies with immunohistochemical analysis and various reporter mice have established the temporal development pattern of the enteric nervous system (ENS), including the onset of spontaneous and induced electrical activity in embryonic mouse gut. 4, [8] [9] [10] [11] [17] [18] [19] [20] [21] [22] [23] [24] [25] However, such knowledge about the developing human gut is lacking. In this study, we report that the onset of evoked electrical activity in the human fetal ENS appears at approximately EW16. We show that such activity appears to coincide with increases in gene expression of various ion channels known to modulate enteric action potentials, and we clearly establish the temporal development of a number of neural subtypes and enteric glia between EW12 and EW16. Furthermore, we confirm such temporal development with gene expression studies that highlight the developmental processes required for the establishment of a functional ENS.
In this study, the proximal colon was chosen as a site of investigation for both technical and translational purposes. The identification of the caecum in intestinal specimens, across developmental time points, critically allowed for characterization of an anatomically consistent region = (proximal colon) in all specimens. Moreover, the most common congenital gut motility defects, including Hirschsprung disease and slow transit constipation, are known to affect the colonic region. 26 Therefore, a better understanding of the normal ENS developmental timeline, in this region, may provide a means of understanding factors and disease processes that influence functional development.
The formation of circuitry and the development of coordinated electrical activity are crucial requirements for normal bowel function. Disruptions in neuronal plexus formation, density, or diversity severely affect physiological output. 19, [27] [28] [29] [30] [31] In showing the development of several key enteric neuronal subtypes from EW12 to EW14 and the subsequent development of coordinated electrical activity at EW16, we believe that this 4-week developmental time period is critical for the correct assembly of a functional ENS. Of note, the current study examined the development of evoked activity in the proximal colon and, as such, the findings presented may not be reflective of the functional development of other gut segments. Recent studies in animal models have highlighted that routinely available pharmacologic agents such as ibuprofen or vitamin A deficiency can affect ENS development. 32, 33 Hence, it is conceivable that in this critical developmental window in the early second trimester, the ENS is vulnerable to insult, which may be clinically relevant in terms of subtle disease processes.
Our findings from both RNA-sequencing and qRT-PCR analyses suggest a general up-regulation of a number of ion channels and increasing diversity of enteric neurons and glia over this period. The methodology used in the current study involved whole-tissue segments rather than direct isolation of native ENCCs. As such, the inclusion of nonENCCs may have diluted the expression of specific ENCCrelated genes and may account for the failure of our comparison analysis to reach statistical significance. A previous murine study showed a similar general up-regulation of ion channel expression between E11.5 and E14. 5 . 34 This study made use of endogenous yellow fluorescent protein (YFP) expression in murine ENCCs to enable specific isolation of ENCCs at each time point via fluorescence activated cell sorting. Although previous studies have successfully isolated small numbers of ENCCs from human fetal tissue 15,35 using p75 fluorescence-activated cell sorting isolation, the limited availability of fetal human gut samples and the need for physiological and immunohistochemical analyses in the current study prevented the specific isolation of sufficient numbers of ENCCs. Furthermore, 1 embryo per time point was examined for this initial analysis, and the groups presented in the differential expression analysis represent technical replicates. Therefore, our differential expression analysis should be viewed as an indicator of the transcriptional difference between the developmental stages examined.
In this study, we clearly show that coordinated compound activation of enteric networks occurs between EW14 and EW16, showing a critical period of gut development that may underpin functionality in later life. The finding that 4 of 5 human colon samples at EW14 did not display electrical activity, compared with 3 of 3 at EW16 that did display Ca 2þ transients upon electrical stimulation, suggests that this window of activation is consistent across numerous fetal gut specimens. Similarly, immunohistochemical analysis of the temporal development of neural subtypes and glia was found to be consistent across multiple specimens. The staging method used in this study relies on measurement of either knee-to-heel length or foot length. Although this method has been validated, the resolution of gestational age in weeks may lead to minor discrepancies in precise staging. It is therefore likely that the sample (1 of 5) that displayed electrical activity at EW14 in response to stimulation may represent late-stage EW14/EW15 tissue. Spontaneous Ca 2þ oscillations were not resolved in the human ENS specimens examined. Previous investigations in murine gut samples suggest that spontaneous calcium transients occur from E11.5 to E15.5, which can propagate to neighboring ENCCs. This spontaneous calcium activity appeared to be a transient phenomenon, as such activity was not observed in either E10.5 or E16.5 tissue. 10 Given that this transient activity in mice commences before full colonization of the gut and then ceases shortly after ENCCs have completed their rostrocaudal migration along the length of the gut, it is likely that spontaneous calcium activity was not observed in human specimens because of the timeframe of our current study, because complete colonization of the human gut has been shown to occur by approximately EW7.
The finding that inhibitory neuronal subtypes in the colon, including nNOS and VIP, appear to arise at approximately EW14 after excitatory neuronal subtypes (VAChT and Sub P) suggests that there is an extended period of neuronal modulation after ENCC colonization. In murine studies, ChAT þ neurons were found to develop in the colon from E14.5, 10 whereas nNOS þ neurons have previously been shown to arise between E12.5 8 and E13.5 (E11.5 þ 48-hour culture). 18 The reasons behind the contrasting findings in terms of neuronal birth-dating are unclear. Unfortunately, in our hands, various immunohistologic assays with ChAT antibodies in human gut tissue proved unsuccessful. However, complexities in the transcriptional and posttranscriptional regulation of ChAT and VAChT may account for the different timings observed in the 2 species. 36 Our finding that synaptic proteins are expressed at EW12, several weeks before the onset of coordinated activity, suggests that although physical expression of synaptic proteins exists in the human ENS by the end of the first trimester, further modulation and refinement of the mechanisms involved in neuronal excitability occurs in the following weeks to allow coordinated, networked activity by EW16. We show that acetylcholine stimulation, at EW14 did not elicit compound activation of the presumptive ENS and that blockade of nicotinic acetylcholine receptors at EW16 did not block stimulation-induced Ca 2þ transients in the fetal ENS. This suggests that both synaptic and postsynaptic nicotinic specializations are not critical factors in the development of evoked calcium activity in the early human ENS.
Previous studies have suggested that neural activity may act to influence ENS wiring. 17, 18 During mouse development, neurons transition from inactive to action potential firing with increasing voltage-gated sodium channel expression and increasing Na þ current density. 17 All embryonic action potentials in murine neurons in that study appeared to be TTX sensitive. Similarly, in our current study, coordinated firing of enteric neural networks upon stimulation at EW16 were TTX sensitive. Taken together, these results suggest that a similar developmental pattern may be responsible for action potential firing in early human fetal gut. The requirement for coordinated firing of the human ENS relatively early in gestation remains unclear. Although there is accumulation of meconium in the fetal human gut at the early stages, fully developed motor patterns are not established until well into postnatal development. [37] [38] [39] Therefore, further studies will be required to establish how the development of ENS activity in the human gut influences not only neural development per se but also the impact on associated cell types in the neuromuscular syncytium that ultimately dictate motility.
We conclude that this study provides critical evidence describing the birth-dating of neuronal subtypes and the subsequent emergence of coordinated electrical activity in the human ENS and thus may provide a platform for future studies to understand the developmental and pathophysiological basis of enteric neuropathies in the human gastrointestinal tract.
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. 
Candidate Gene Expression Evaluation
Two types of output were generated: one in which reads were allowed to map to more than one location (lenient analysis) and another in which we allowed only uniquely mapped reads (stringent analysis). Lenient analysis was used for differential analysis, and stringent alignment was used to validate the specificity of the expression of paralogous genes of interest (sodium voltage-gated channel a subunits, sodium channel epithelial b subunits, synapsins, and semaphorins). When evaluating expression, we considered a gene to be expressed if it had an average CPM value of !2 for all genes across triplicates, uncertain when CPM values were between 1 and 2, and not expressed if the average CPM value was <1. If embryologic stages differed significantly (FDR 0.05), we considered the direction of the change to be true if not we could not determine the directionality of the change with RNA sequencing. Raw data and the output of the lenient and stringent alignments, including CPM, total counts, RKPM, TPM, and statistics, are available at the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/), under the accession number GSE111307.
Causal Network Analysis Using Ingenuity Pathway Analysis
Differently expressed genes (false discovery rate 0.05) with a fold change ! 1.5 and a RPKM group mean >1 were uploaded to Ingenuity Pathway Analysis (Qiagen) for downstream pathway analysis. The causal networks analysis algorithm embedded in the Ingenuity Pathway Analysis tool was used to infer cause-effect relationships from the gene expression data results. 41 As thresholds for significance, we used a P value .05 and a Z-score of 2. 
